U.S. Markets closed

$1.5 Billion Interventional Oncology Market by Procedure, Product, Application, and End User - Global Forecast to 2025

DUBLIN, Aug. 16, 2019 /PRNewswire/ -- The "Interventional Oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product, Application (Liver, Lung, Breast), and End User - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global interventional oncology market is estimated to grow at a CAGR of 7.7% from 2019 to reach $1,506.3 million by 2025.

The global interventional oncology market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2025-by procedure (embolization [TARE, TACE], ablation thermal ablation [microwave, RF ablation]), by product (embolization [SIR-spheres, theraspheres], ablation), application (liver, lung, breast), end-user (hospitals, ambulatory care center), and geography.

The study also evaluates industry competitors and analyzes the market at regional and country level.

Embolization products segment is estimated to command the largest share of the global interventional oncology market in 2019 and expected to witness high growth during the forecast period mainly due to the preference for embolization procedures owing to its benefits such as better clinical outcomes, high specificity & sensitivity towards tumor cells, and efficiency in targeting and detection of tumor lesions. However, the fastest growth in this market is mostly driven by increasing application base of embolization products across various cancer types, rising coverage of reimbursement across the globe, and increasing incidence of cancer & related mortality.

The interventional oncology market for hospitals (end-user segment) is estimated to command the largest share of the global market in 2019. This is attributed to the large volume of patients visiting hospitals for diagnosis & treatment of any healthcare concern including a critical disease like cancer owing to the wide presence, easy accessibility and better healthcare facilities in hospitals.

North America commanded the largest share of the global interventional oncology market, mainly attributed to the factors such as well-established healthcare system including hospitals and ASCs in the North American region, greater adoption of advanced technologies, high level of awareness & spending towards overall healthcare and cancer, growing incidence & prevalence of cancer, presence of key players, and high level of Medicare & Medicaid health insurance coverage.

Key Topics Covered:

1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.3. Key Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers Growing Preference for Minimally invasive Treatment Procedures Increasing Incidence & Prevalence of Cancer Rising Number of Hospitals Technological Advancements in the Field of Radiology
4.2.2. Restraints Potential Risks Associated with Interventional Oncology Procedures High Cost Associated with Interventional Oncology Procedures Paucity of Skilled Healthcare Professionals
4.2.3. Opportunities Significant Growth Opportunities from Emerging Asian and Latin American Markets Introduction of Cloud-Based Medical Imaging
4.2.4. Trend Growing Integration of Image-Guided Solutions with Interventional Oncology Procedures

5. Interventional Oncology Market, by Procedure
5.1. Introduction
5.2. Tumor Embolization
5.2.1. Transarterial Radioembolization (TARE)
5.2.2. Transarterial Chemoembolization (TACE)
5.2.3. Bland Embolization
5.3. Tumor Ablation
5.3.1. Thermal Ablation Radiofrequency Ablation (RFA) Microwave Ablation (MWA) Cryoablation Other Thermal Ablation Procedures
5.3.2. Non-Thermal Ablation

6. Interventional Oncology Market, by Product
6.1. Introduction
6.2. Tumor Embolization
6.2.1. Radioembolic Agents Sir-Spheres TheraSphere QuiremSpheres
6.2.2. Non-Radioactive Embolic Agents Microspheres Particles (PVA Particles and Gelfoam Particles) Drug-Eluting Beads (DEBs)
6.3. Tumor Ablation
6.3.1. Tumor Ablation Devices/Generators
6.3.2. Consumables & Accessories

7. Interventional Oncology Market, by Application
7.1. Introduction
7.2. Liver Cancer
7.3. Lung Cancer
7.4. Breast Cancer
7.5. Prostate Cancer
7.6. Kidney Cancer
7.7. Bone Metastasis
7.8. Other Cancers

8. Interventional Oncology Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Ambulatory Surgery Centres
8.4. Research and Academia

9. Interventional Oncology Market, by Geography

10. Competitive Landscape
10.1. Growth Strategies
10.2. Competitive Benchmarking
10.3. Market Share Analysis (2018)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)

  • AngioDynamics Inc.
  • Boston Scientific Corporation
  • BTG plc
  • C. R. Bard Inc.
  • Cook Medical LLC
  • HealthTronics Inc.
  • IceCure Medical Ltd.
  • IMBiotechnologies Ltd.
  • Medtronic plc
  • MedWaves Inc.
  • Merit Medical Systems Inc.
  • Neuwave Medical Inc.
  • Profound Medical Corp
  • Sanarus Technologies Inc.
  • Sirtex Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical

For more information about this report visit https://www.researchandmarkets.com/r/7ykc3a

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


View original content:http://www.prnewswire.com/news-releases/1-5-billion-interventional-oncology-market-by-procedure-product-application-and-end-user---global-forecast-to-2025--300903021.html